Treatment of primary and of the following forms of secondary pulmonary hypertension: connective tissue disease pulmonary hypertension, drug- induced pulmonary hypertension, portopulmonary hypertension, pulmonary hypertension associated with congenital heart disease and chronic thromboembolic pulmonary hypertension
Note for Guidance on Clinical investigation of medicinal products for the treatment of peripheral arterial occlusive disease Zur Stellungnahme freigegeben im November 2000